NEW YORK (360Dx) – Swiss diagnostics firm ProteoMedix said today it has raised CHF 5.2 million ($5.3 million) in equity funding from existing investors.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.